IXJvsXLVETF Comparison
VS
iShares Global Healthcare ETF (IXJ) belongs to the Global Large Cap segment. State Street Health Care Select Sector SPDR ETF (XLV) is part of the US Health Care segment. IXJ's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Consumer Cyclicals. In contrast, XLV's top sector exposures are Healthcare, Consumer Non-Cyclicals and Finance. IXJ is more expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.08% for XLV. IXJ is up 16.67% year-to-date (YTD) with -$490M in YTD flows. XLV performs better with 20.93% YTD performance, and +$1.68B in YTD flows. Run a side-by-side ETF comparison of IXJ and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IXJ vs XLV performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/30/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IXJ XLV | +10.14%+9.86% | +11.22%+13.56% | +16.67%+20.93% | +25.25%+30.25% | +49.00%+56.97% | +37.74%+50.06% |
| Flows | IXJ XLV | -$103M+$1.51B | +$40M+$1.47B | -$490M+$1.68B | -$351M+$2.38B | -$619M-$2.81B | +$13M+$4.41B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IXJ XLV | +16.93%+17.21% | +15.94%+16.47% | +14.42%+14.98% | +14.66%+15.28% |
| Max drawdown | IXJ XLV | -6.30%-5.81% | -10.83%-10.51% | -18.04%-17.05% | -18.04%-17.05% |
| Max drawdown duration | IXJ XLV | 55d56d | 122d116d | 490d444d | 490d444d |
Trading data
IXJ | XLV | |
Last sale 10/30/2026 at 1:30 PM | $112.66 | $184.87 |
| Previous close 10/29/2026 | $111.74 | $184.04 |
| Consolidated volume 10/29/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
IXJ | XLV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
IXJ | XLV | |
|---|---|---|
| Last price | $112.66 | $184.87 |
| 1D performance | +0.82% | +0.45% |
| AuM | $4.65 B | $49.10 B |
| E/R | 0.38% | 0.08% |
Characteristics
IXJ | XLV | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | iShares | State Street Investment Management |
| Benchmark | S&P Global 1200 Health Care (Sector) Capped Index | S&P Health Care Select Sector Index |
| N° of holdings | 109 | 61 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 13, 2001 | December 16, 1998 |
| ESG | No | No |
Advertisement
Exposure
Countries
IXJ
USA
71.85%
Switzerland
9.64%
Other
18.51%
XLV
USA
97.6%
Other
2.4%
Sectors
IXJ
Healthcare
97.24%
Other
2.76%
XLV
Healthcare
97.95%
Other
2.05%
Advertisement
Diversification
IXJ
Total weight of top 15 holdings out of 15
57.19%
XLV
Total weight of top 15 holdings out of 15
71.29%
Top 15 holdings
Data as of September 30, 2026
IXJ
Eli Lilly & Co.
10.43%
Johnson & Johnson
7.19%
AbbVie, Inc.
5.21%
Merck & Co., Inc.
4.43%
UnitedHealth Group, Inc.
4.07%
Roche Holding AG
3.64%
Novartis AG
3.26%
AstraZeneca PLC
3.13%
Thermo Fisher Scientific, Inc.
3.09%
Amgen, Inc.
2.82%
Gilead Sciences, Inc.
2.29%
Abbott Laboratories
2.12%
Pfizer Inc.
2.01%
Intuitive Surgical, Inc.
1.78%
Danaher Corp.
1.72%
XLV
Eli Lilly & Co.
15.13%
Johnson & Johnson
10.43%
AbbVie, Inc.
7.55%
Merck & Co., Inc.
5.86%
UnitedHealth Group, Inc.
5.38%
Thermo Fisher Scientific, Inc.
4.08%
Amgen, Inc.
3.72%
Gilead Sciences, Inc.
3.02%
Abbott Laboratories
2.79%
Pfizer Inc.
2.66%
Intuitive Surgical, Inc.
2.35%
Danaher Corp.
2.27%
Vertex Pharmaceuticals, Inc.
2.17%
Bristol Myers Squibb Co.
2.08%
Medtronic Plc
1.81%
Frequently asked questions about IXJ and XLV
How have the IXJ and XLV ETFs performed in 2026?
As of October 30, 2026, IXJ is up 16.67% year-to-date (YTD), while XLV has returned 20.93%. That puts XLV better performer ahead so far this year.
Which ETF is attracting more investor money: IXJ or XLV?
Year-to-date, the IXJ ETF saw -$490M in flows, compared to +$1.68B for XLV.
Which ETF is more volatile: IXJ or XLV?
Over the past year, IXJ had a volatility of 15.94%, while XLV experienced 16.47%.
Which ETF is bigger: IXJ or XLV?
As of October 30, 2026, IXJ holds $4.65 B in assets under management (AUM), while XLV manages $49.10 B.
What sectors do the IXJ and XLV ETFs invest in?
IXJ leans toward sectors like Healthcare. Meanwhile, XLV focuses on Healthcare.
What are the top holdings of the IXJ ETF and XLV ETF?
IXJ top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. XLV holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: IXJ or XLV?
IXJ holds 110 securities with 57.19% of its assets in the top 15. XLV has 61 securities and a top 15 weight of 71.29%.
Advertisement
Latest news about IXJ & XLV
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
